Interestingly, a homolog of Ankrd2, Ankrd23 [1] was recently identified as a potential dual-role cancer driver gene acting as an oncogene in renal clear-cell carcinoma, and a tumor suppressor in bladder urothelial carcinoma [30]. The gene discussed is ANKRD23; the disease is bladder transitional cell carcinoma.